DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

13.37 11.23 13.97 17.83
P/S ratio
0.72 0.62 0.75 1.03
P/FCF ratio
6.36 5.56 6.12 8.01
P/Operating CF
11.38 15.60 32.28 29.41
P/B ratio
0.00 0.00 0.00 0.00
EV/Sales
1.43 1.33 1.47 1.75
EV/EBITDA
6.93 6.57 7.25 8.62
EV/FCF
12.65 11.94 12.00 13.59
Current Ratio
1.36 1.29 1.42 1.47
Net Debt/EBITDA
13.87 12.96 15.10 13.45
Debt/Equity
(33.86) (28.02) (22.49) (22.44)
Earnings Yield
7.48% 8.91% 7.16% 5.61%
Free Cash Flow Yield
15.72% 18.00% 16.35% 12.48%
Free Cash Flow per Share
9.51 5.35 3.30 4.95
Book value per Share
(4.22) (5.03) (7.07) (7.44)
Free Cash Flow
685.38 397.13 222.53 320.92
EV/EBIT
9.30 8.87 9.74 11.50
Other line items

Show all line items

Columns are period end dates